MELD 3.0 bests MELD-Na in predicting liver transplant waitlist mortality for adolescents

WASHINGTON — MELD 3.0 more accurately predicted the risk for 90-day waitlist mortality compared with MELD-Na among adolescent patients on a liver transplant waitlist, according to research presented at The Liver Meeting.

“Adolescents, which we have defined here as children or teenagers aged 12 to 17, constitute a unique and often overlooked waitlist cohort that is distinct from younger children and adults,” Allison J. Kwong, MD, a transplant hepatologist specializing in chronic liver disease at Stanford University, said. Read more in Healio.